Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Dual IRE1 RNase functions dictate glioblastoma development.

Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jégou G, Pallares-Lupon N, Schmit K, Le Reste PJ, Etcheverry A, Mosser J, Barroso K, Vauléon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E.

EMBO Mol Med. 2018 Mar;10(3). pii: e7929. doi: 10.15252/emmm.201707929.

2.

Regulation of tumor-stroma interactions by the unfolded protein response.

Obacz J, Avril T, Rubio-Patiño C, Bossowski JP, Igbaria A, Ricci JE, Chevet E.

FEBS J. 2017 Dec 14. doi: 10.1111/febs.14359. [Epub ahead of print] Review.

PMID:
29239107
3.

CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.

Avril T, Etcheverry A, Pineau R, Obacz J, Jegou G, Jouan F, Le Reste PJ, Hatami M, Colen RR, Carlson BL, Decker PA, Sarkaria JN, Vauléon E, Chiforeanu DC, Clavreul A, Mosser J, Chevet E, Quillien V.

Clin Cancer Res. 2017 Dec 1;23(23):7360-7374. doi: 10.1158/1078-0432.CCR-17-1549. Epub 2017 Sep 22.

4.

Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells.

Hrstka R, Podhorec J, Nenutil R, Sommerova L, Obacz J, Durech M, Faktor J, Bouchal P, Skoupilova H, Vojtesek B.

Cancer Invest. 2017 May 28;35(5):313-324. doi: 10.1080/07357907.2017.1309546. Epub 2017 Apr 12.

PMID:
28402678
5.

Endoplasmic reticulum proteostasis in glioblastoma-From molecular mechanisms to therapeutic perspectives.

Obacz J, Avril T, Le Reste PJ, Urra H, Quillien V, Hetz C, Chevet E.

Sci Signal. 2017 Mar 14;10(470). pii: eaal2323. doi: 10.1126/scisignal.aal2323. Review.

PMID:
28292956
6.

Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.

Obacz J, Brychtova V, Podhorec J, Fabian P, Dobes P, Vojtesek B, Hrstka R.

Onco Targets Ther. 2015 Jun 24;8:1523-32. doi: 10.2147/OTT.S82235. eCollection 2015.

7.

The role of AGR2 and AGR3 in cancer: similar but not identical.

Obacz J, Takacova M, Brychtova V, Dobes P, Pastorekova S, Vojtesek B, Hrstka R.

Eur J Cell Biol. 2015 Mar-Apr;94(3-4):139-47. doi: 10.1016/j.ejcb.2015.01.002. Epub 2015 Jan 21. Review.

PMID:
25666661
8.

Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.

Obacz J, Pastorekova S, Vojtesek B, Hrstka R.

Mol Cancer. 2013 Aug 14;12(1):93. doi: 10.1186/1476-4598-12-93. Review.

Supplemental Content

Support Center